| |
| |
|
| Insider
Information: |
Grande Alicia |
| Relationship: |
VP, Treasurer and CFO |
| City: |
Coral Gables |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
55,813 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$885,752 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
55,813 |
|
|
| Total
Value |
$885,752 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
16
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 5.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Catalyst Pharmaceutical Partners... |
CPRX |
VP, Treasurer and CFO |
2023-12-27 |
55,813 |
2008-01-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
45 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CPRX |
Catalyst Pharmaceutical P... |
Chief Accounting Officer |
• – – |
2008-11-24 |
4 |
B |
$1.85 |
$1,850 |
D/D |
1,000 |
7,346 |
2.66 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Accounting Officer |
• – – |
2008-11-25 |
4 |
B |
$1.85 |
$4,625 |
D/D |
2,500 |
9,846 |
2.66 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Accounting OfficerOffice |
• – – |
2007-01-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,000 |
|
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Chief Accounting Officer |
• – – |
2008-01-01 |
4 |
A |
$3.01 |
$4,051 |
D/D |
1,346 |
16,346 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Controller & CAO |
• – – |
2009-11-18 |
4 |
B |
$0.65 |
$3,250 |
D/D |
5,000 |
19,846 |
2.66 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
Controller & CAO |
• – – |
2009-11-19 |
4 |
B |
$0.65 |
$2,730 |
D/D |
4,200 |
24,046 |
2.66 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2022-11-22 |
4 |
S |
$16.53 |
$1,983,240 |
D/D |
(120,000) |
27,442 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2022-12-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,667 |
42,109 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2012-05-30 |
4 |
B |
$0.57 |
$9,861 |
D/D |
17,300 |
46,346 |
2.74 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-02-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,718) |
50,557 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-03-22 |
4 |
S |
$16.41 |
$689,528 |
D/D |
(41,784) |
50,557 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-03-28 |
4 |
S |
$16.37 |
$962,786 |
D/D |
(58,216) |
50,557 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-03-29 |
4 |
S |
$16.67 |
$835,100 |
D/D |
(50,000) |
50,557 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-12-08 |
4 |
S |
$14.25 |
$571,000 |
D/D |
(40,000) |
50,557 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-12-11 |
4 |
S |
$13.74 |
$825,780 |
D/D |
(60,000) |
50,557 |
0 |
% |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,166 |
53,275 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-12-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,410) |
55,813 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,666 |
59,223 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2012-07-03 |
4 |
B |
$0.54 |
$10,980 |
D/D |
20,000 |
66,346 |
2.74 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-03-22 |
4 |
OE |
$0.79 |
$33,009 |
D/D |
41,784 |
89,081 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-12-08 |
4 |
OE |
$1.13 |
$45,200 |
D/D |
40,000 |
90,557 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-03-29 |
4 |
OE |
$1.13 |
$56,500 |
D/D |
50,000 |
100,557 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-03-28 |
4 |
OE |
$0.79 |
$45,991 |
D/D |
58,216 |
108,773 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2023-12-11 |
4 |
OE |
$1.13 |
$67,800 |
D/D |
60,000 |
110,557 |
0 |
- |
|
| CPRX |
Catalyst Pharmaceutical P... |
VP, Treasurer and CFO |
• – – |
2022-11-15 |
4 |
S |
$15.77 |
$946,080 |
D/D |
(60,000) |
147,442 |
0 |
% |
|
45 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
